SCHEMBL22241558

SCHEMBL22241558

BC(=O)[C@H](C)NC(=O)C(NC(=O)C(CN)N1C(=O)C=CC1=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29558676 0.89 CTSB (0.31) —
SCHEMBL17721386 0.78 P2RX4 (0.34) —
SCHEMBL17254417 0.72 DNMT1 (0.32) —
SCHEMBL15395836 0.70 DNMT1 (0.35) —
SCHEMBL19868965 0.70 DNMT1 (0.35) —
SCHEMBL22241547 0.70 CASP1 (0.31) —
SCHEMBL25831382 0.70 PTGS1 (0.45) —
SCHEMBL20887626 0.69 PKM (0.33) —
SCHEMBL22314407 0.69 DNMT1 (0.31) —
SCHEMBL22224180 0.69 DNMT1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057585-B1 PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS SEATTLE GENETICS INC (US) 2020-07-22 — — EP disclosed
Send feedback